ClinicalTrials.Veeva

Menu

Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy

Y

Yi Yang

Status

Completed

Conditions

Acute Ischemic Stroke

Treatments

Device: Transcranial Doppler.

Study type

Interventional

Funder types

Other

Identifiers

NCT05618535
EBPHPAIS-URT

Details and patient eligibility

About

The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.

Full description

Hemodynamic stability can prevent hypoperfusion or hyperperfusion after reperfusion therapy. It has been reported in a large number of literatures that body position has an effect on hemodynamics, but the effect of different body positions on the hemodynamics of patients undergoing ultra-early reperfusion therapy is not clear. In this study, we hypothesized that the hemodynamics of patients undergoing ultra-early reperfusion therapy would differ between different positions.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age≥18 years, < 80 years, regardless of sex;
  • Patients with clinically confirmed acute ischemic stroke who received intravenous thrombolysis or emergency endovascular treatment;
  • Baseline National Institute of Health stroke scale(NIHSS)score ≤25;
  • Baseline Glasgow Coma Scale (GCS) ≥8;
  • Signed and dated informed consent is obtained

Exclusion criteria

  • The patient has clear indications or contraindications, such as active vomiting, spinal cord injury;
  • Clinicians considered that the assigned body position could not be maintained; Patients unable to cooperate with all noninvasive beat-by-beat continuous BP monitoring;
  • Poor temporal window penetration;
  • Patients with diseases that seriously affect hemodynamics, such as atrial fibrillation, anemia, and hyperthyroidism;
  • Previous history of atrial fibrillation or ECG showing atrial fibrillation or arrhythmia;
  • Pregnant or lactating women;
  • Poor treatment compliance;
  • Complicated with severe systemic diseases, such as heart failure, respiratory failure, renal failure, gastrointestinal bleeding, coagulopathy, malignant tumors.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Zero position
Sham Comparator group
Description:
All monitoring was done from 9 to 11 a.m., and the whole monitoring process was carried out in a specific and quiet environment at 20-24℃ to avoid other auditory and visual stimuli. After 10min of the relaxed supine position, the blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured in the 0° position for 5min.
Treatment:
Device: Transcranial Doppler.
30 degrees position
Experimental group
Description:
Within 30 seconds after the 0° position measurement completion, the subjects were transferred to the 30° position and rested for 15 minutes under the 30° position. In other words, a washout period of 15 minutes was established between two measurements to ensure the stability of vital signs and avoid confounding effects. The blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured again for 5 minutes after the vital signs were stable.
Treatment:
Device: Transcranial Doppler.

Trial contacts and locations

1

Loading...

Central trial contact

Yi Yang, MD,PhD; Zhenni Guo, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems